Risk Evaluation and Mitigation Strategies

Risk Evaluation and Mitigation Strategies (REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand-name or generic drugs.

Source: Wikipedia — Risk Evaluation and Mitigation Strategies (CC BY-SA 4.0)